Sorry, you need to enable JavaScript to visit this website.

Hasta aquí, todo bien...

Al parecer reúne los requisitos básicos para este estudio de la vacuna contra la COVID-19. Introduzca abajo su información para encontrar una ubicación del estudio cerca de usted. Una vez que haya seleccionado un centro, el personal del estudio de investigación la contactará para ver si reúne los requisitos de inscripción.

Hasta aquí, todo bien...

Parece que su hijo cumple los requisitos básicos para este estudio de la vacuna contra la COVID-19. Sin embargo, solo el personal del estudio de investigación podrá determinar completamente si su hijo reúne los requisitos para inscribirse. Introduzca su información de contacto y seleccione “Encontrar un centro” para ver si hay un centro del estudio inscribiendo participantes en su zona.

Nota: Los padres de familia y tutores deben introducir su información de contacto, no la de su hijo.

So far – So good!

Your adolescent appears to meet the basic requirements for this COVID-19 vaccine study. However, only the research study staff can fully determine if your adolescent qualifies to enroll. Please enter your contact information and select “Find a Site” to see if there is a study site enrolling in your area.

Note: Parents and guardians should input their contact information, not their adolescent’s.

Sorry, you are not eligible or we may not be recruiting your age group at this time...

Thank you so much for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

Lo sentimos, su hijo no es elegible en este momento...

Gracias por su interés en este estudio de la vacuna contra la COVID-19 y por responder nuestras preguntas. Comuníquese con su proveedor de atención médica si tiene alguna pregunta médica. Además, considere ingresar su información a continuación para que se comuniquen con usted acerca de las oportunidades de estudios de investigación futuros.

Sorry, your adolescent is not eligible at this time...

Thank you for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

A Targeted Approach Against COVID-19

Learn more about the Pfizer & BioNTech COVID-19 Omicron Variant BA.4/BA.5 Targeted Vaccine Study for previously vaccinated and boosted people.

Please note: we are currently recruiting participants ages 56 years and older.

Header

Pregunta 1 de 2

Are you at least 56 years old?

Pregunta 2 de 2

Have you received only 3 prior doses of the Pfizer & BioNTech COMIRNATY® COVID-19 vaccine, with the third dose occurring 5 to 12 months ago?

Por favor seleccione una dirección válida completa.

Elija una ubicación

Please select a research site near you. If you don't see a site near you, then select “Los centros enumerados aquí no me resultan convenientes”. Y un representante del estudio se pondrá en contacto con usted si se abre un centro en su área.

Los centros enumerados aquí no son cómodos para mí.

About The Study

This study is evaluating the safety, tolerability, and immune response generated by a single dose of a redesigned bivalent Omicron BA.4/BA.5 study vaccine in children 12-17 years old and adults who have received only 3 prior doses of the Pfizer & BioNTech COMIRNATY® vaccine. About 500 participants will be enrolled in the United States.

We are currently recruiting adults 56 years and older.

An Important Contribution

Receiving a COVID-19 vaccine and booster is still the best strategy for protecting yourself and others from serious illness. However, the level of protection against COVID-19 has been shown to decrease with time, just like it does after natural infection. For this reason, researchers are evaluating if a redesigned version of an investigational vaccine may improve and extend the immune response, particularly against BA.4 and BA.5, two new versions of the Omicron variant that are now responsible for the majority of COVID-19 cases in the United States.

By choosing to volunteer, you will represent others like you – in age, gender, race, ethnicity, and from communities like yours. Including people from all backgrounds will improve the effectiveness of the COVID-19 vaccine for everyone.

Joining a clinical trial is an important and personal decision. Thank you for considering this study.

Header Image

What to Expect

icon

This study does not include a placebo (injection with no active ingredient). All participants will receive a single dose of the study vaccine. Adult participants will be randomly assigned to receive 1 of 2 possible dose levels of the study vaccine. Doses will be given as an injection in the upper arm.

icon

Participants will be enrolled in the study for about 6 months and will need to attend at least 5 study visits during this time.

icon

Participants may be reimbursed for expenses and time related to completing study activities.

Pfizer Logo
BioNTech Logo